Mongersen and SMAD-7 Inhibition, Not a Lucky 7 for Patients With IBD: When Trial Design Is as Important as Disease Therapy. [electronic resource]

By: Contributor(s): Producer: 20210222Description: 687-688 p. digitalISSN:
  • 1572-0241
Subject(s): Online resources: In: The American journal of gastroenterology vol. 115
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.